The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the ...

A TOR-targeting cancer drug unexpectedly extends yeast lifespan through a newly discovered metabolic feedback loop.

A new federal negotiation round reshapes how your most expensive diabetes and cancer treatments will be priced under Medicare ...

A next-generation drug tested in yeast was found to extend lifespan and slow aging by influencing a major growth-control pathway. Researchers also uncovered an unexpected role for agmatinases, enzymes ...

Food and Drug Administration Commissioner Marty Makary is under renewed scrutiny by Trump officials amid continued turmoil at ...

Molecular glues are revolutionizing cancer therapy by targeting undruggable proteins for degradation, enhancing precision ...

Cancer-fighting antibody drugs are designed to penetrate tumor cells and release a lethal payload deep within, but too often ...

CMS announced massive price reductions for 15 critical drugs, including Xtandi, Ibrance, and Janumet. See the full list and ...

In what researchers are calling a ”breakthrough hiding in plain sight,” scientists have redesigned a 40-year-old deworming ...

The government has approved new reimbursement rules enabling patients with advanced non-small cell lung cancer (NSCLC) to use ...

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

The Mikaela Naylon Give Kids a Chance Act now heads to the Senate, aiming to fast-track treatments and give children with ...